Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy.

Gachoud, David; Bertelli, Claire; Rufer, Nathalie

Gachoud, David; Bertelli, Claire; Rufer, Nathalie.

Affiliation

Gachoud D; Department of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Bertelli C; Medical Education Unit, School of Medicine, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Rufer N; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Br J Haematol ; 200(2): e25-e27, 2023 01.

Article in En | MEDLINE | ID: mdl-36354067

Subject(s)

COVID-19; Humans; COVID-19/therapy; COVID-19/etiology; COVID-19 Serotherapy; SARS-CoV-2; Immunization, Passive/adverse effects; B-Lymphocytes; Antibodies, Viral; Antibodies, Neutralizing

Key words

COVID-19 convalescent plasma; SARS-CoV-2 viral loads; anti-CD20 therapy; immunocompromised

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Guideline Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google